CONTANGO SILVER & GOLD INC.

CTGO

CIK 0001502377 · Quarterly mode · latest period FY2025 (Q3) (ending 2025-09-30) · sourced from SEC EDGAR

At a glance · FY2025 (Q3)

Revenue
$0
Operating Income
$25M
↑+9.8% +$2Mvs FY2024 (Q3)
Gross Profit
$0

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
42/100
  • Profitability
    100ROIC 84.5% (10% = solid, 20%+ = moat)
  • Liquidity
    20Current Ratio 0.90 (above 1.5 = solid)
  • Leverage
    33D/E 1.35 (under 0.5 = conservative)
  • Efficiency
    0Asset Turnover -0.05x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +53.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin -1447.9% · trend -970.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CTGO's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$34.31
Total enterprise IV
$443M
Diluted shares
0.01B
Terminal PV
$321M (72% of total)
Year-5 FCF
$38M
YearProjected FCFDiscounted PV
+1$28M$25M
+2$30M$25M
+3$32M$24M
+4$35M$24M
+5$38M$23M
Terminal$517M$321M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Stock-based comp (TTM)
$3M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$172M
everything owned
Total liabilities
$147M
everything owed
Stockholders' equity
$25M
shareholder claim
Net debt
$-31M
Net cash position ($31M)

Recent performance · 60 quarters

Revenue↑+53.2% +$2M
$-2M
Net Income↑+44.5% +$4M
$-5M
Free Cash Flow
$23M
Operating Margin↓-830.6pts
-1447.9%

Drill down